Conviction
$ Value
$461K
Shares
60,229
Price
$8
Filed
Feb 24
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
LINDSTROM RICHARD L MD
Title
—
CIK
0001242177
Roles
Transaction Details
Transaction Date
2026-02-20
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
246,933
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 to $7.69, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. | Includes 43,559 shares transferred from the Lindstrom Family No 2 Limited Partnership to the reporting person.
Filing Info
LINDSTROM RICHARD L MD's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-20 | OCUL | ▲ | $461K ★ |
| 2025-06-11 | OCUL | A | $0 |
| 2025-06-11 | OCUL | A | $0 |
| 2025-05-23 | LNSR | A | $0 |
| 2025-05-08 | OCUL | ▲ | $70K |
Other Insiders at OCUL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Heier Jeffrey S.
Chief Scientific Officer
|
— | $25K | 2026-02-23 |
|
Dugel Pravin
See Remarks
|
— | $1.3M | 2026-04-09 |
|
Notman Donald
Chief Operating Officer
|
— | $205K | 2026-02-12 |
|
Kaiser Peter
Chief Development Officer
|
— | $23K | 2026-02-23 |
|
Nayak Sanjay
Chief Strategy Officer
|
— | $108K | 2026-02-23 |
|
Waheed Nadia
Chief Medical Officer
|
— | $98K | 2026-02-20 |
|
Robinson David Wayne
Global CCO
|
— | — | 2026-01-21 |